A new candidate vaccine for SARS-CoV-2 moves to human trials. Beijing based biotechnology company company, Sinovac, describes protection of macaque monkeys from infection by SARS-CoV-2 by the vaccine candidate.
A Vaccine Candidate Protects Non-Human Primates From SARS-CoV-2 Infection
